FindMyRecallSubscribe
Class I: serious health riskTerminated

Junp Hydration MegMan Performance Booster Recall

MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in…

Junp Hydration LLC · Brooklyn, NY

Risk level
Class I
Reported by FDA
Feb 16, 2022
Recall ID
D-0557-2022
Check your lot numberHow we source this data

Summary

Junp Hydration recalled MegMan Performance Booster starting Feb 4, 2022. The FDA classified it as Class I (serious health risk) and published enforcement report D-0557-2022 on Feb 16, 2022. Reason: Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug. Status: Terminated.

Why it was recalled

Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Product description

MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2, ASIN B08Z74KS88

Lot numbers, UPCs & expiration codes

Lot # 2010291, Exp 01/07/2024

Where it was sold

Product was distributed nationwide in the USA via Amazon Marketplace

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0557-2022
Classification
Class I
Status
Terminated
Recall initiated
Feb 4, 2022
FDA report date
Feb 16, 2022
Quantity
750 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Junp Hydration LLC

Original FDA data

Every field from FDA enforcement report D-0557-2022, exactly as published.

Show all FDA fields
City
Brooklyn
State
NY
Status
Terminated
Country
United States
Event ID
89543
Address
1013 Mcdonald Ave
Code information
Lot # 2010291, Exp 01/07/2024
Postal code
11230-1009
Report date
Feb 16, 2022
Product type
Drugs
Recall number
D-0557-2022
Classification
Class I
Recalling firm
Junp Hydration LLC
Product quantity
750 cartons
Termination date
Jun 9, 2022
Reason for recall
Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Voluntary / mandated
Voluntary: Firm initiated
Product description
MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2, ASIN B08Z74KS88
Distribution pattern
Product was distributed nationwide in the USA via Amazon Marketplace
Recall initiation date
Feb 4, 2022
Initial firm notification
Press Release
Center classification date
Feb 11, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0557-2022, published Feb 16, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls